Camille L. Bedrosian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 6,461 shares at $14.58 ($94K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Open-market sale of $94k AMLX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |
| AMLX | SELL | 2024-12-03 | $30K | — | Filing → |